SCHEMBL2442745

SCHEMBL2442745

CNS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 1.00
CA2 P00918 4/20 1.00
CA12 O43570 2/20 1.00
CA3 P07451 2/20 1.00
CA4 P22748 2/20 1.00
CA6 P23280 2/20 1.00
CA5A P35218 2/20 1.00
CA7 P43166 2/20 1.00
CA9 Q16790 2/20 1.00
CA13 Q8N1Q1 2/20 1.00
CA14 Q9ULX7 2/20 1.00
CA5B Q9Y2D0 2/20 1.00
SMN1; SMN2 Q16637 2/20 0.64
GAA P10253 2/20 0.64
MMP1 P03956 1/20 0.61
MMP2 P08253 1/20 0.61
MMP9 P14780 1/20 0.61
MMP8 P22894 1/20 0.61
MMP13 P45452 1/20 0.61
LMNA P02545 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11512091 0.98 CA1 (0.95) CA1CA2CA12CA3CA4
SCHEMBL10617367 0.98 CA1 (0.95) CA1CA2CA12CA3CA4
Phosphonic Acid SCHEMBL9435884 0.90 CA2 (0.81) CA1CA2CA12CA3CA4
SCHEMBL7009516 0.88 SMN1; SMN2 (0.81) CA1CA2CA12CA3CA4
SCHEMBL7629070 0.87 SMN1; SMN2 (0.80) CA1CA2CA12CA3CA4
SCHEMBL9435894 0.84 CA1 (0.70) CA1CA2CA12CA3CA4
SCHEMBL10448337 0.82 CA1 (0.69) CA1CA2CA12CA3CA4
4-Chloroaniline SCHEMBL2226595 0.81 CA12 (0.67) CA1CA2CA12CA3CA4
SCHEMBL3073626 0.81 CA1 (0.68) CA1CA2CA12CA3CA4
SCHEMBL8080277 0.80 SMN1; SMN2 (0.70) CA1CA2CA12CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2197879-B1 C7-SUBSTITUTED CAMPTOTHECIN ANALOGS BIONUMERIK PHARMACEUTICALS INC (US) 2014-01-22 EP claimed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US claimed
EP-2197879-A1 C7-SUBSTITUTED CAMPTOTHECIN ANALOGS BIONUMERIK PHARMACEUTICALS, INC. (US) 2010-06-23 EP claimed
US-7687496-B2 C7-substituted camptothecin analogs BIONUMERIK PHARMACEUTICALS, INC. (US) 2010-03-30 US claimed
WO-2009051580-A1 C7-SUBSTITUTED CAMPTOTHECIN ANALOGS BIONUMERIK PHARMACEUTICALS, INC. (US) 2009-04-23 WO claimed
US-20090099224-A1 C7- substituted camptothecin analogs BIONUMERIK PHARMACEUTICALS, INC. 2009-04-16 US claimed
US-3980673-A INSECTICIDES, ACARICIDES BAYER AKTIENGESELLSCHAFT (DT) 1976-09-14 US claimed
WO-2023219007-A1 THERMOSETTING RESIN COMPOSITION, MOLDED ARTICLE, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIAL, AND FIBER-REINFORCED COMPOSITE MATERIAL 東レ株式会社 2023-11-16 WO disclosed
EP-4092012-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC. (US) 2022-11-23 EP disclosed
CN-110857278-B Method for synthesizing N-methylsulfonamide in water 南京理工大学 2022-04-15 CN disclosed
WO-2021163493-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-19 WO disclosed
CN-112430200-A Method for preparing 1, 2-alkene diamide compound 江西师范大学 2021-03-02 CN disclosed
CN-109320441-B Method for efficiently preparing alkynylamide compound 江西师范大学 2021-01-26 CN disclosed
US-5594003-A HYPOTENSIVE AGENTS DR. KARL THOMAE GMBH (DE) 1997-01-14 US disclosed
US-5591762-A HYPOTENSIVE AGENTS DR. KARL THOMAE GMBH (DE) 1997-01-07 US disclosed
US-5587393-A ANGIOTENSIN ANTAGONIST USEFUL IN TREATING HYPERTENSION DR. KARL THOMAE GMBH (DE) 1996-12-24 US disclosed
EP-0659738-A1 N-(Carbonyl, carbonimidoyl, carbonothioyl) sulfonamide charge control agents and toners and developers EASTMAN KODAK COMPANY (US) 1995-06-28 EP disclosed
US-5405727-A Electrophotography EASTMAN KODAK COMPANY (US) 1995-04-11 US disclosed
US-5385925-A Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them DR. KARL THOMAE GMBH (DE) 1995-01-31 US disclosed
US-3980673-A INSECTICIDES, ACARICIDES BAYER AKTIENGESELLSCHAFT (DT) 1976-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS STS, ARSA, TST CA1 4599/4885CA2 3102/4885CA12 4631/4885
US-20090099224-A1 C7- substituted camptothecin analogs ABCB1, ABCC1, ABCG2 CA1 2729/4885CA2 4105/4885CA12 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.